metabolic pathway modulators (PharmaQest)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namemetabolic pathway modulators (PharmaQest)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsFatigue Syndrome, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmaQest Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmaQest Pty Ltd
Active IndicationsN/A
Inactive IndicationsFatigue Syndrome, Chronic

Other Information

ATC CodeN/A
Related LinksN/A